openPR Logo
Press release

Alpha Thalassemia Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, MOA, ROA by DelveInsight | Genmedicn Biopharma Ltd., Bristol-Myers Squibb, Agios Pharma

10-01-2024 03:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Alpha Thalassemia Pipeline Dynamics 2024: FDA Approvals,

(Las Vegas, Nevada, United States) As per DelveIns ight's assessment, globally, Alpha Thalassemia pipeline constitutes 4+ key companies continuously working towards developing 5+ Alpha Thalassemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Alpha Thalassemia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

"Alpha Thalassemia Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/alpha-thalassemia-pipeline-insight-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alpha Thalassemia Market.

Some of the key takeaways from the Alpha Thalassemia Pipeline Report:

*
Companies across the globe are diligently working toward developing novel Alpha Thalassemia treatment therapies with a considerable amount of success over the years.

*
Alpha Thalassemia companies working in the treatment market are Forma Therapeutics, Inc., Genmedicn Biopharma Ltd., Bristol-Myers Squibb, Agios Pharmaceuticals, and others, are developing therapies for the Alpha Thalassemia treatment

*
Emerging Alpha Thalassemia therapies in the different phases of clinical trials are- Etavopivat tablets, GMCN-508A, Luspatercept, Mitapivat, and others are expected to have a significant impact on the Alpha Thalassemia market in the coming years.

*
In January 2024, Agios Pharmaceuticals reported positive outcomes in a Phase III ENERGIZE trial of mitapivat for patients with non-transfusion-dependent alpha- or beta-thalassemia, meeting primary and two key secondary endpoints. The company intends to seek regulatory approval for mitapivat as a thalassemia treatment by year-end, incorporating data from the second Phase III ENERGISE-T study (NCT04770779) for adults with transfusion-dependent alpha-thalassemia or beta-thalassemia.

Alpha Thalassemia Overview

Alpha thalassemia is a genetic disorder characterized by a deficiency in the production of alpha globin chains, which are essential components of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This deficiency results in a reduced amount of hemoglobin and red blood cells, leading to anemia.

Get a Free Sample PDF Report to know more about Alpha Thalassemia Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/alpha-thalassemia-pipeline-insight-pipeline-insight [https://www.delveinsight.com/report-store/alpha-thalassemia-pipeline-insight-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Emerging Alpha Thalassemia Drugs Under Different Phases of Clinical Development Include:

*
Etavopivat tablets: Forma Therapeutics, Inc.

*
GMCN-508A: Genmedicn Biopharma Ltd.

*
Luspatercept: Bristol-Myers Squibb

*
Mitapivat: Agios Pharmaceuticals

Alpha Thalassemia Route of Administration

Alpha Thalassemia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

*
Oral

*
Parenteral

*
Intravenous

*
Subcutaneous

*
Topical

Alpha Thalassemia Molecule Type

Alpha Thalassemia Products have been categorized under various Molecule types, such as

*
Monoclonal Antibody

*
Peptides

*
Polymer

*
Small molecule

*
Gene therapy

*
Product Type

Alpha Thalassemia Pipeline Therapeutics Assessment

*
Alpha Thalassemia Assessment by Product Type

*
Alpha Thalassemia By Stage and Product Type

*
Alpha Thalassemia Assessment by Route of Administration

*
Alpha Thalassemia By Stage and Route of Administration

*
Alpha Thalassemia Assessment by Molecule Type

*
Alpha Thalassemia by Stage and Molecule Type

DelveInsight's Alpha Thalassemia Report covers around 5+ products under different phases of clinical development like

*
Late-stage products (Phase III)

*
Mid-stage products (Phase II)

*
Early-stage product (Phase I)

*
Pre-clinical and Discovery stage candidates

*
Discontinued & Inactive candidates

*
Route of Administration

Further Alpha Thalassemia product details are provided in the report. Download the Alpha Thalassemia pipeline report to learn more about the emerging Alpha Thalassemia therapies [https://www.delveinsight.com/sample-request/alpha-thalassemia-pipeline-insight-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Alpha Thalassemia Pipeline Analysis:

The Alpha Thalassemia pipeline report provides insights into

*
The report provides detailed insights about companies that are developing therapies for the treatment of Alpha Thalassemia with aggregate therapies developed by each company for the same.

*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alpha Thalassemia Treatment.

*
Alpha Thalassemia key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

*
Alpha Thalassemia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Alpha Thalassemia market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Alpha Thalassemia drugs and therapies [https://www.delveinsight.com/sample-request/alpha-thalassemia-pipeline-insight-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Alpha Thalassemia Pipeline Market Drivers

*
Increasing Prevalence genetic disorders and advancement in healthcare technologies, growing demand for treatment for Alpha Thalassemia are some of the important factors that are fueling the Alpha Thalassemia Market.

Alpha Thalassemia Pipeline Market Barriers

*
However, lack of available appropriate treatments and procedures, high cost of treatment and other factors are creating obstacles in the Alpha Thalassemia Market growth.

Scope of Alpha Thalassemia Pipeline Drug Insight

*
Coverage: Global

*
Key Alpha Thalassemia Companies: Forma Therapeutics, Inc., Genmedicn Biopharma Ltd., Bristol-Myers Squibb, Agios Pharmaceuticals, and others

*
Key Alpha Thalassemia Therapies: Etavopivat tablets, GMCN-508A, Luspatercept, Mitapivat, and others

*
Alpha Thalassemia Therapeutic Assessment: Alpha Thalassemia current marketed and Alpha Thalassemia emerging therapies

*
Alpha Thalassemia Market Dynamics: Alpha Thalassemia market drivers and Alpha Thalassemia market barriers

Request for Sample PDF Report for Alpha Thalassemia Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/alpha-thalassemia-pipeline-insight-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Alpha Thalassemia Report Introduction

2. Alpha Thalassemia Executive Summary

3. Alpha Thalassemia Overview

4. Alpha Thalassemia- Analytical Perspective In-depth Commercial Assessment

5. Alpha Thalassemia Pipeline Therapeutics

6. Alpha Thalassemia Late Stage Products (Phase II/III)

7. Alpha Thalassemia Mid Stage Products (Phase II)

8. Alpha Thalassemia Early Stage Products (Phase I)

9. Alpha Thalassemia Preclinical Stage Products

10. Alpha Thalassemia Therapeutics Assessment

11. Alpha Thalassemia Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Alpha Thalassemia Key Companies

14. Alpha Thalassemia Key Products

15. Alpha Thalassemia Unmet Needs

16 . Alpha Thalassemia Market Drivers and Barriers

17. Alpha Thalassemia Future Perspectives and Conclusion

18. Alpha Thalassemia Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=alpha-thalassemia-pipeline-dynamics-2024-fda-approvals-therapeutic-advances-moa-roa-by-delveinsight-genmedicn-biopharma-ltd-bristolmyers-squibb-agios-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alpha Thalassemia Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, MOA, ROA by DelveInsight | Genmedicn Biopharma Ltd., Bristol-Myers Squibb, Agios Pharma here

News-ID: 3674612 • Views:

More Releases from ABNewswire

Monique Lore Stinson Joins Sorghum United as Vice President of Marketing and Media
10-01-2024 | Arts & Culture
ABNewswire
Monique Lore Stinson Joins Sorghum United as Vice President of Marketing and Med …
LINCOLN, NE - September 27, 2024 - Sorghum United [https://sorghumunited.com] is proud to announce the appointment of Monique Lore Stinson as its new Vice President of Marketing and Media, effective immediately. In her new role, Stinson will lead Sorghum United's marketing efforts as the organization scales its impact on the global stage, utilizing her vast experience in media, marketing, and brand development. Nate Blum, CEO of Sorghum United, expressed his excitement
Silexion Therapeutics Unveils Promising Preclinical Data for SIL-204 Just Days After New LODER Data: Advancing the Fight Against Pancreatic Cancer
Silexion Therapeutics Unveils Promising Preclinical Data for SIL-204 Just Days A …
Silexion Therapeutics (NASDAQ: SLXN) revealed new preclinical data for SIL-204, showing significant tumor reduction in pancreatic cancer models. This follows positive Phase 2 results for their LODER technology, building momentum. SIL-204 targets KRAS mutations and could reshape cancer treatment. Silexion is planning Phase 2/3 trials by 2026 and aims to expand SIL-204's use to other KRAS-driven cancers like colorectal cancer. Just days after a previous announcement on new Phase 2 data
Sophros Recovery Hosts Veterans Day Celebration in Tampa with Resources, Wellness, and Fun
Sophros Recovery Hosts Veterans Day Celebration in Tampa with Resources, Wellnes …
Tampa, Fla. - Sophros Recovery [https://www.sophrosrecovery.com/] is proud to announce a special Veterans Day Celebration on Tuesday, Oct. 22nd, in Tampa. The celebration will honor Veterans and bring the local community together with a variety of engaging activities, food, and educational opportunities. The Veteran's Day Celebration will be from 4:00 p.m. to 7:00 p.m. at 10500 University Center Drive, Suite 215, Tampa, Florida, 33612. It will feature various wellness activities, Veteran
Innovative Spaces: How PF & A Design is Redefining Modern Living
Innovative Spaces: How PF & A Design is Redefining Modern Living
PF & A Design is redefining modern living through innovative building design, interior solutions, and comprehensive architect services. By prioritizing sustainability, embracing technology, and focusing on client needs, the firm has created spaces that enhance both functionality and aesthetic appeal. As the world of architecture continues to evolve, PF & A Design stands ready to lead the way, shaping the future of how we experience our living environments. In today's rapidly

All 5 Releases


More Releases for Alpha

Alpha Heater Reviews: Does Alpha Heater Really Work?
Alpha heater reviews The winter can be a tough time when it comes to one’s pocket in the sense that most people spend a lot on money on electricity bill due to the increased cost of heating and electricity. The winter is a season we all need to be prepared. It really require a careful and adequate arrangement to make sure everything is in order before its coming. As the winter
Alpha Heater in Canada: Black Friday Alpha Heater Amazon Deals
Get Alpha Heater For The Most Discounted Price >> https://rebrand.ly/AlphaHeaterCA As temperature levels remain to fall across the USA and also Canada, The Alpha Heater could be an useful home appliance, one that heats up things up effectively and also swiftly. Utilizing this device, you can bring heat into any space of your home in an efficient fashion. Plus, the dropping temperature levels, together with work-at-home norms as well as the
Alpha Heater Canada Review: Where to Buy Alpha Heater in Canada
Winter heat is a popular option with personal heaters. The Alpha Heater can be used by individuals to heat their homes or take them to work. Alpha Heater’s new design allows for 30% reductions in monthly electric bills compared to traditional heaters. Did you know that traditional heaters can consume up to 1,500 watts an hour? Others use slightly higher or lower amounts. Imagine how your electricity bill looks after a
Alpha Heater Review 2021: Shocking Facts about Alpha portable heater Reviews
Soonest, snow will be piling up on just about every doorstep around the country and you’ll be considering all options to stay warm during the winter. Don't be afraid Alpha heater Review is here to guide you through. Whether you’re a naturally cold person or want to save some money space heaters may be the answer to all your cold-weather issues. One easy way to get the job done? Alpha portable
Alpha Xtra Boost Reviews - Where to Buy Alpha Xtra Boost Pills Online?
Alpha Xtra Boost Review: As men age, their capacity to act in bed deteriorates. Numerous men find that they are unable to satisfy their accomplice in a similar fashion as they did previously. This can initiate a never-ending rify in a relationship. In their edginess, a few men consider the guidance of supplements that may induce serious side-effects. Nonetheless, these are far distant from the correct decision. Alpha Xtra Boost
Alpha Xtra Boost Reviews - Does Alpha Xtra Boost Really Work?
Reduced testosterone among men is a growing concern. However, while many consider taking the aid of chemicals for this purpose, it is instead recommended to go for dietary formulas instead. Alpha Xtra Boost is one such natural supplement that provides users with a number of ways to boost their performance in bed. Get Alpha Xtra Boost Today >> https://rebrand.ly/o0aijnb What is Alpha Xtra Boost? This is a new dietary supplement that focuses